Prevalenza delle manifestazioni cardiovascolari nella sindrome di Marfan

Translated title of the contribution: Prevalence of cardiovascular manifestations in Marfan syndrome

Maria Cristina Porciani, Monica Attanasio, Valentina Lepri, Ilaria Lapini, Gabriele Demarchi, Luigi Padeletti, Guglielmina Pepe, Rosanna Abbate, Gian Franco Gensini

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Background. Marfan syndrome is an inherited connective tissue disorder with an autosomic dominant transmission. The prevalence is 1:5000-10 000 and the clinical major criteria involve the skeletal and ocular apparatus and the cardiovascular and central nervous system. The main cause of morbidity is represented by the thoracic aortic dissection/aneurysm that is responsible for 80% of the deaths. Methods. We performed a clinical study on 227 patients enrolled at our Clinical and Research Marfan and Related Disorders Center. The aim of this study was to describe the prevalence of cardiovascular manifestation in this cohort of patients. Results. Aortic dilation was present in 172 patients (75.8%), mitral valve prolapse in 179 (78.9%). Aortic insufficiency was present in 83 patients (36.6%), mitral insufficiency in 165 (72.7%). When analyzed separately, in <10-year and > 40-year patients aortic dilation was more prevalent than mitral valve prolapse. Three patients presented with interatrial septal defect, 4 aortic bicuspid valve; 23 had a history of ventricular and supraventricular arrhythmias, and in 2 patients an implantable cardioverter device had been implanted. Fifty-seven patients were treated with beta-blockers and 28 had been operated for aortic aneurysmal dilation. Conclusions. In Marfan syndrome mitral valve prolapse and aortic dilation are the main cardiovascular manifestations, interatrial septal defect and aortic bicuspid valve had the same prevalence than in subjects without Marfan syndrome. These data refer to our first patient evaluation; further studies are needed to evaluate the progression and the natural history of cardiovascular manifestations in Marfan syndrome.

Original languageItalian
Pages (from-to)647-652
Number of pages6
JournalItalian Heart Journal Supplement
Volume5
Issue number8
Publication statusPublished - 2004

Fingerprint

Marfan Syndrome
Mitral Valve Prolapse
Dilatation
Thoracic Aortic Aneurysm
Mitral Valve Insufficiency
Natural History
Connective Tissue
Dissection
Cardiac Arrhythmias
Central Nervous System
Morbidity
Equipment and Supplies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Porciani, M. C., Attanasio, M., Lepri, V., Lapini, I., Demarchi, G., Padeletti, L., ... Gensini, G. F. (2004). Prevalenza delle manifestazioni cardiovascolari nella sindrome di Marfan. Italian Heart Journal Supplement, 5(8), 647-652.

Prevalenza delle manifestazioni cardiovascolari nella sindrome di Marfan. / Porciani, Maria Cristina; Attanasio, Monica; Lepri, Valentina; Lapini, Ilaria; Demarchi, Gabriele; Padeletti, Luigi; Pepe, Guglielmina; Abbate, Rosanna; Gensini, Gian Franco.

In: Italian Heart Journal Supplement, Vol. 5, No. 8, 2004, p. 647-652.

Research output: Contribution to journalArticle

Porciani, MC, Attanasio, M, Lepri, V, Lapini, I, Demarchi, G, Padeletti, L, Pepe, G, Abbate, R & Gensini, GF 2004, 'Prevalenza delle manifestazioni cardiovascolari nella sindrome di Marfan', Italian Heart Journal Supplement, vol. 5, no. 8, pp. 647-652.
Porciani MC, Attanasio M, Lepri V, Lapini I, Demarchi G, Padeletti L et al. Prevalenza delle manifestazioni cardiovascolari nella sindrome di Marfan. Italian Heart Journal Supplement. 2004;5(8):647-652.
Porciani, Maria Cristina ; Attanasio, Monica ; Lepri, Valentina ; Lapini, Ilaria ; Demarchi, Gabriele ; Padeletti, Luigi ; Pepe, Guglielmina ; Abbate, Rosanna ; Gensini, Gian Franco. / Prevalenza delle manifestazioni cardiovascolari nella sindrome di Marfan. In: Italian Heart Journal Supplement. 2004 ; Vol. 5, No. 8. pp. 647-652.
@article{feb08430d0fd4874b23787391127a297,
title = "Prevalenza delle manifestazioni cardiovascolari nella sindrome di Marfan",
abstract = "Background. Marfan syndrome is an inherited connective tissue disorder with an autosomic dominant transmission. The prevalence is 1:5000-10 000 and the clinical major criteria involve the skeletal and ocular apparatus and the cardiovascular and central nervous system. The main cause of morbidity is represented by the thoracic aortic dissection/aneurysm that is responsible for 80{\%} of the deaths. Methods. We performed a clinical study on 227 patients enrolled at our Clinical and Research Marfan and Related Disorders Center. The aim of this study was to describe the prevalence of cardiovascular manifestation in this cohort of patients. Results. Aortic dilation was present in 172 patients (75.8{\%}), mitral valve prolapse in 179 (78.9{\%}). Aortic insufficiency was present in 83 patients (36.6{\%}), mitral insufficiency in 165 (72.7{\%}). When analyzed separately, in <10-year and > 40-year patients aortic dilation was more prevalent than mitral valve prolapse. Three patients presented with interatrial septal defect, 4 aortic bicuspid valve; 23 had a history of ventricular and supraventricular arrhythmias, and in 2 patients an implantable cardioverter device had been implanted. Fifty-seven patients were treated with beta-blockers and 28 had been operated for aortic aneurysmal dilation. Conclusions. In Marfan syndrome mitral valve prolapse and aortic dilation are the main cardiovascular manifestations, interatrial septal defect and aortic bicuspid valve had the same prevalence than in subjects without Marfan syndrome. These data refer to our first patient evaluation; further studies are needed to evaluate the progression and the natural history of cardiovascular manifestations in Marfan syndrome.",
keywords = "Aorta, Marfan syndrome, Mitral valve prolapse",
author = "Porciani, {Maria Cristina} and Monica Attanasio and Valentina Lepri and Ilaria Lapini and Gabriele Demarchi and Luigi Padeletti and Guglielmina Pepe and Rosanna Abbate and Gensini, {Gian Franco}",
year = "2004",
language = "Italian",
volume = "5",
pages = "647--652",
journal = "Italian Heart Journal Supplement",
issn = "1129-4728",
publisher = "Centro Editoriale Pubblicitario Italiano",
number = "8",

}

TY - JOUR

T1 - Prevalenza delle manifestazioni cardiovascolari nella sindrome di Marfan

AU - Porciani, Maria Cristina

AU - Attanasio, Monica

AU - Lepri, Valentina

AU - Lapini, Ilaria

AU - Demarchi, Gabriele

AU - Padeletti, Luigi

AU - Pepe, Guglielmina

AU - Abbate, Rosanna

AU - Gensini, Gian Franco

PY - 2004

Y1 - 2004

N2 - Background. Marfan syndrome is an inherited connective tissue disorder with an autosomic dominant transmission. The prevalence is 1:5000-10 000 and the clinical major criteria involve the skeletal and ocular apparatus and the cardiovascular and central nervous system. The main cause of morbidity is represented by the thoracic aortic dissection/aneurysm that is responsible for 80% of the deaths. Methods. We performed a clinical study on 227 patients enrolled at our Clinical and Research Marfan and Related Disorders Center. The aim of this study was to describe the prevalence of cardiovascular manifestation in this cohort of patients. Results. Aortic dilation was present in 172 patients (75.8%), mitral valve prolapse in 179 (78.9%). Aortic insufficiency was present in 83 patients (36.6%), mitral insufficiency in 165 (72.7%). When analyzed separately, in <10-year and > 40-year patients aortic dilation was more prevalent than mitral valve prolapse. Three patients presented with interatrial septal defect, 4 aortic bicuspid valve; 23 had a history of ventricular and supraventricular arrhythmias, and in 2 patients an implantable cardioverter device had been implanted. Fifty-seven patients were treated with beta-blockers and 28 had been operated for aortic aneurysmal dilation. Conclusions. In Marfan syndrome mitral valve prolapse and aortic dilation are the main cardiovascular manifestations, interatrial septal defect and aortic bicuspid valve had the same prevalence than in subjects without Marfan syndrome. These data refer to our first patient evaluation; further studies are needed to evaluate the progression and the natural history of cardiovascular manifestations in Marfan syndrome.

AB - Background. Marfan syndrome is an inherited connective tissue disorder with an autosomic dominant transmission. The prevalence is 1:5000-10 000 and the clinical major criteria involve the skeletal and ocular apparatus and the cardiovascular and central nervous system. The main cause of morbidity is represented by the thoracic aortic dissection/aneurysm that is responsible for 80% of the deaths. Methods. We performed a clinical study on 227 patients enrolled at our Clinical and Research Marfan and Related Disorders Center. The aim of this study was to describe the prevalence of cardiovascular manifestation in this cohort of patients. Results. Aortic dilation was present in 172 patients (75.8%), mitral valve prolapse in 179 (78.9%). Aortic insufficiency was present in 83 patients (36.6%), mitral insufficiency in 165 (72.7%). When analyzed separately, in <10-year and > 40-year patients aortic dilation was more prevalent than mitral valve prolapse. Three patients presented with interatrial septal defect, 4 aortic bicuspid valve; 23 had a history of ventricular and supraventricular arrhythmias, and in 2 patients an implantable cardioverter device had been implanted. Fifty-seven patients were treated with beta-blockers and 28 had been operated for aortic aneurysmal dilation. Conclusions. In Marfan syndrome mitral valve prolapse and aortic dilation are the main cardiovascular manifestations, interatrial septal defect and aortic bicuspid valve had the same prevalence than in subjects without Marfan syndrome. These data refer to our first patient evaluation; further studies are needed to evaluate the progression and the natural history of cardiovascular manifestations in Marfan syndrome.

KW - Aorta

KW - Marfan syndrome

KW - Mitral valve prolapse

UR - http://www.scopus.com/inward/record.url?scp=21644469675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21644469675&partnerID=8YFLogxK

M3 - Articolo

C2 - 15554020

AN - SCOPUS:21644469675

VL - 5

SP - 647

EP - 652

JO - Italian Heart Journal Supplement

JF - Italian Heart Journal Supplement

SN - 1129-4728

IS - 8

ER -